Assessment of Clinically Meaningful Improvements in Self-Reported Walking Ability in Participants with Multiple Sclerosis: Results from the Randomized, Double-Blind, Phase ... View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2019-01

AUTHORS

Jeremy Hobart, Tjalf Ziemssen, Peter Feys, Michael Linnebank, Andrew D. Goodman, Rachel Farrell, Raymond Hupperts, Andrew R. Blight, Veronica Englishby, Manjit McNeill, Ih Chang, Gabriel Lima, Jacob Elkins, On behalf of the ENHANCE study investigators

ABSTRACT

BACKGROUND: Walking impairment is a hallmark of multiple sclerosis (MS). It affects > 90% of individuals over time, reducing independence and negatively impacting health-related quality of life, productivity, and daily activities. Walking impairment is consistently reported as one of the most distressing impairments by individuals with MS. Prolonged-release (PR)-fampridine previously has been shown to improve objectively measured walking speed in walking-impaired adults with MS. The impact of PR-fampridine from the perspective of the individual with MS warrants full and detailed examination. OBJECTIVE: The objective of this study was to evaluate whether PR-fampridine has a clinically meaningful effect on self-reported walking ability in walking-impaired participants with MS. METHODS: ENHANCE was a phase III, randomized, double-blind, placebo-controlled study of PR-fampridine 10 mg twice daily in walking-impaired individuals age 18-70 years with either relapsing or progressive forms of MS and an Expanded Disability Status Scale (EDSS) score of 4.0-7.0 at screening. Participants were stratified by EDSS score (≤ 6.0 or 6.5-7.0) at randomization to ensure a balanced level of disability in the treatment groups. The primary endpoint was the proportion of participants with a mean improvement in the 12-item Multiple Sclerosis Walking Scale (MSWS-12) score exceeding the predefined threshold for clinically meaningful improvement (≥ 8 points) over 24 weeks. Secondary endpoints included the proportion with ≥ 15% improvement in Timed Up and Go (TUG) speed, and mean changes in Multiple Sclerosis Impact Scale physical impact subscale (MSIS-29 PHYS), Berg Balance Scale (BBS), and ABILHAND scores over 24 weeks. RESULTS: In total, 636 participants with MS were randomized (PR-fampridine, n = 317; placebo, n = 319; modified intention-to-treat sample: PR-fampridine, n = 315; placebo, n = 318). At baseline in the PR-fampridine and placebo groups, 46% and 51% had a progressive form of MS, median [range] EDSS scores were 6.0 [4.0-7.0] and 5.5 [4.0-7.0], mean [range] MSWS-12 scores were 63.6 [0-100] and 65.4 [0-100], and mean [range] TUG speed was 0.38 [0.0-1.0] and 0.38 [0.0-1.2] feet/s, respectively. A significantly higher percentage of PR-fampridine-treated participants (136/315 [43.2%]) had clinically meaningful improvement in MSWS-12 score over 24 weeks versus placebo (107/318 [33.6%]; odds ratio 1.61 [95% confidence interval 1.15-2.26]; p = 0.006). For PR-fampridine versus placebo, significantly more participants had a ≥ 15% improvement in TUG speed, and there was significantly greater mean improvement in MSIS-29 PHYS score (p < 0.05); numerical improvements that were not statistically significant were observed in BBS/ABILHAND. Adverse events that were more common in the PR-fampridine group than placebo group (difference ≥ 3%) by Medical Dictionary for Regulatory Activities (MedDRA®) Preferred Term were urinary tract infection and insomnia. There were no seizures reported. CONCLUSIONS: PR-fampridine treatment resulted in sustained, clinically meaningful improvements over 24 weeks in self-reported walking and functional ability in walking-disabled participants with MS. CLINICALTRIALS. GOV IDENTIFIER: NCT02219932. More... »

PAGES

1-19

References to SciGraph publications

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s40263-018-0586-5

DOI

http://dx.doi.org/10.1007/s40263-018-0586-5

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1110507428

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/30535670


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "University Hospitals Plymouth NHS Trust", 
          "id": "https://www.grid.ac/institutes/grid.418670.c", 
          "name": [
            "Plymouth University Peninsula Schools of Medicine and Dentistry, University Hospitals Plymouth NHS Trust, N13 ITTC Building, Plymouth Science Park, PL6 8BX, Plymouth, Devon, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hobart", 
        "givenName": "Jeremy", 
        "id": "sg:person.01332375141.47", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01332375141.47"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "TU Dresden", 
          "id": "https://www.grid.ac/institutes/grid.4488.0", 
          "name": [
            "Center of Clinical Neuroscience, Carl Gustav Carus University Clinic, Technical University of Dresden, Dresden, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ziemssen", 
        "givenName": "Tjalf", 
        "id": "sg:person.0767421434.26", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0767421434.26"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Hasselt", 
          "id": "https://www.grid.ac/institutes/grid.12155.32", 
          "name": [
            "BIOMED-REVAL, University of Hasselt, Diepenbeek, Belgium"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Feys", 
        "givenName": "Peter", 
        "id": "sg:person.0715702051.84", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0715702051.84"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Helios Klinik Hagen Ambrock", 
          "id": "https://www.grid.ac/institutes/grid.488890.5", 
          "name": [
            "HELIOS Klinik Hagen-Ambrock, University Witten/Herdecke, Hagen, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Linnebank", 
        "givenName": "Michael", 
        "id": "sg:person.01051055517.12", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01051055517.12"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Rochester", 
          "id": "https://www.grid.ac/institutes/grid.16416.34", 
          "name": [
            "School of Medicine and Dentistry, University of Rochester, Rochester, NY, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Goodman", 
        "givenName": "Andrew D.", 
        "id": "sg:person.016506013472.31", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016506013472.31"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "National Hospital for Neurology and Neurosurgery", 
          "id": "https://www.grid.ac/institutes/grid.436283.8", 
          "name": [
            "National Hospital for Neurology and Neurosurgery, University College London Hospitals and University College London Institute of Neurology, London, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Farrell", 
        "givenName": "Rachel", 
        "id": "sg:person.012135403634.76", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012135403634.76"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Zuyderland Medisch Centrum", 
          "id": "https://www.grid.ac/institutes/grid.416905.f", 
          "name": [
            "Zuyderland Medical Center, Sittard, The Netherlands"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hupperts", 
        "givenName": "Raymond", 
        "id": "sg:person.0660503170.46", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0660503170.46"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Acorda Therapeutics (United States)", 
          "id": "https://www.grid.ac/institutes/grid.417402.4", 
          "name": [
            "Acorda Therapeutics, Inc, Ardsley, NY, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Blight", 
        "givenName": "Andrew R.", 
        "id": "sg:person.01210332036.09", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01210332036.09"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Biogen (United Kingdom)", 
          "id": "https://www.grid.ac/institutes/grid.476070.2", 
          "name": [
            "Biogen, Maidenhead, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Englishby", 
        "givenName": "Veronica", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Biogen (United Kingdom)", 
          "id": "https://www.grid.ac/institutes/grid.476070.2", 
          "name": [
            "Biogen, Maidenhead, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "McNeill", 
        "givenName": "Manjit", 
        "id": "sg:person.01346517240.04", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01346517240.04"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Biogen (United States)", 
          "id": "https://www.grid.ac/institutes/grid.417832.b", 
          "name": [
            "Biogen, Cambridge, MA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Chang", 
        "givenName": "Ih", 
        "id": "sg:person.01025220556.38", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01025220556.38"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Biogen (United States)", 
          "id": "https://www.grid.ac/institutes/grid.417832.b", 
          "name": [
            "Biogen, Cambridge, MA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lima", 
        "givenName": "Gabriel", 
        "id": "sg:person.014347450275.96", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014347450275.96"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Biogen (United States)", 
          "id": "https://www.grid.ac/institutes/grid.417832.b", 
          "name": [
            "Biogen, Cambridge, MA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Elkins", 
        "givenName": "Jacob", 
        "id": "sg:person.0632630700.05", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0632630700.05"
        ], 
        "type": "Person"
      }, 
      {
        "familyName": "On behalf of the ENHANCE study investigators", 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1177/2055217315596993", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000226856"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1177/2055217315596993", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000226856"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(09)60442-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000475441"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1177/1352458514567553", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000622362"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1177/1352458514567553", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000622362"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1177/1352458514567553", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000622362"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1177/1352458508088916", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001802066"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1177/1352458508088916", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001802066"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1177/1352458508088916", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001802066"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1080/09638280701191859", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001944038"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1177/1352458515581436", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003469455"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1177/1352458515581436", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003469455"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1177/1352458515581436", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003469455"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1177/1352458514563591", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004177395"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1177/1352458514563591", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004177395"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1177/1352458514563591", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004177395"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1177/1352458512444498", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004638456"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1177/1352458512444498", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004638456"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1177/1352458512444498", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004638456"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1177/1352458515606809", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005629673"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1177/1352458515606809", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005629673"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1177/1352458515606809", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005629673"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1080/00325481.2015.1000229", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006623226"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0003-9993(98)90167-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006801651"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1532-5415.1991.tb01616.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007882864"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1177/1352458514530489", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008373115"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1177/1352458514530489", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008373115"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1177/1352458514530489", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008373115"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1185/03007995.2011.583229", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009204721"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1177/1352458512462919", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009878862"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1177/1352458512462919", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009878862"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1177/1352458512462919", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009878862"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/mrr.0b013e328350b65f", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013266492"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/mrr.0b013e328350b65f", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013266492"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1161/01.str.32.7.1627", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013644901"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.jpain.2007.09.005", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015330748"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/mrr.0b013e328343d4d3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018030857"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/mrr.0b013e328343d4d3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018030857"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/01.npt.0000282258.74325.cf", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018450523"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/01.npt.0000282258.74325.cf", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018450523"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.apmr.2011.01.020", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020096943"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1080/09638280500404289", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021040532"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1371/journal.pone.0165663", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1023865963"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/brain/awn116", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028719948"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1185/03007990903433528", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029987899"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00415-015-7797-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033299561", 
          "https://doi.org/10.1007/s00415-015-7797-1"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/jnnp.2006.105759", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034020704"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/npt.0b013e3182097190", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034657518"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/npt.0b013e3182097190", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034657518"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/ana.22240", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037626702"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.pharmthera.2005.10.006", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041868483"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/acr.20346", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1044241241"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1177/1352458515622695", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045221739"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1177/1352458515622695", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045221739"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1177/1352458515622695", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045221739"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2522/ptj.20060343", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1047265501"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/brain/124.5.962", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1047873684"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.jns.2016.08.052", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1050639148"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1177/1352458514549396", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1050747011"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1177/1352458514549396", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1050747011"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1177/1352458514549396", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1050747011"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2522/ptj.20070251", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1050952303"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1212/wnl.60.1.31", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064381436"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1212/wnl.60.1.31", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064381436"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1212/wnl.60.1.31", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064381436"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.17925/enr.2011.06.02.115", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1068543535"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3310/hta13120", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1071139051"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1076614093", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1212/wnl.0000000000003656", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1083403530"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1212/wnl.0000000000003656", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1083403530"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1212/wnl.0000000000003656", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1083403530"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1177/1352458517720043", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1090894782"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1177/1352458517720043", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1090894782"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1177/1352458517720043", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1090894782"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/9781119013563", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1107030376"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2019-01", 
    "datePublishedReg": "2019-01-01", 
    "description": "BACKGROUND: Walking impairment is a hallmark of multiple sclerosis (MS). It affects\u2009>\u200990% of individuals over time, reducing independence and negatively impacting health-related quality of life, productivity, and daily activities. Walking impairment is consistently reported as one of the most distressing impairments by individuals with MS. Prolonged-release (PR)-fampridine previously has been shown to improve objectively measured walking speed in walking-impaired adults with MS. The impact of PR-fampridine from the perspective of the individual with MS warrants full and detailed examination.\nOBJECTIVE: The objective of this study was to evaluate whether PR-fampridine has a clinically meaningful effect on self-reported walking ability in walking-impaired participants with MS.\nMETHODS: ENHANCE was a phase III, randomized, double-blind, placebo-controlled study of PR-fampridine 10\u00a0mg twice daily in walking-impaired individuals age 18-70\u00a0years with either relapsing or progressive forms of MS and an Expanded Disability Status Scale (EDSS) score of 4.0-7.0 at screening. Participants were stratified by EDSS score (\u2264\u20096.0 or 6.5-7.0) at randomization to ensure a balanced level of disability in the treatment groups. The primary endpoint was the proportion of participants with a mean improvement in the 12-item Multiple Sclerosis Walking Scale (MSWS-12) score exceeding the predefined threshold for clinically meaningful improvement (\u2265\u20098 points) over 24\u00a0weeks. Secondary endpoints included the proportion with\u2009\u2265\u200915% improvement in Timed Up and Go (TUG) speed, and mean changes in Multiple Sclerosis Impact Scale physical impact subscale (MSIS-29 PHYS), Berg Balance Scale (BBS), and ABILHAND scores over 24\u00a0weeks.\nRESULTS: In total, 636 participants with MS were randomized (PR-fampridine, n\u2009=\u2009317; placebo, n\u2009=\u2009319; modified intention-to-treat sample: PR-fampridine, n\u2009=\u2009315; placebo, n\u2009=\u2009318). At baseline in the PR-fampridine and placebo groups, 46% and 51% had a progressive form of MS, median [range] EDSS scores were 6.0 [4.0-7.0] and 5.5 [4.0-7.0], mean [range] MSWS-12 scores were 63.6 [0-100] and 65.4 [0-100], and mean [range] TUG speed was 0.38 [0.0-1.0] and 0.38 [0.0-1.2] feet/s, respectively. A significantly higher percentage of PR-fampridine-treated participants (136/315 [43.2%]) had clinically meaningful improvement in MSWS-12 score over 24\u00a0weeks versus placebo (107/318 [33.6%]; odds ratio 1.61 [95% confidence interval 1.15-2.26]; p\u2009=\u20090.006). For PR-fampridine versus placebo, significantly more participants had a\u2009\u2265\u200915% improvement in TUG speed, and there was significantly greater mean improvement in MSIS-29 PHYS score (p\u2009<\u20090.05); numerical improvements that were not statistically significant were observed in BBS/ABILHAND. Adverse events that were more common in the PR-fampridine group than placebo group (difference\u2009\u2265\u20093%) by Medical Dictionary for Regulatory Activities (MedDRA\u00ae) Preferred Term were urinary tract infection and insomnia. There were no seizures reported.\nCONCLUSIONS: PR-fampridine treatment resulted in sustained, clinically meaningful improvements over 24\u00a0weeks in self-reported walking and functional ability in walking-disabled participants with MS. CLINICALTRIALS.\nGOV IDENTIFIER: NCT02219932.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/s40263-018-0586-5", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1111875", 
        "issn": [
          "1172-7047", 
          "1179-1934"
        ], 
        "name": "CNS Drugs", 
        "type": "Periodical"
      }
    ], 
    "name": "Assessment of Clinically Meaningful Improvements in Self-Reported Walking Ability in Participants with Multiple Sclerosis: Results from the Randomized, Double-Blind, Phase III ENHANCE Trial of Prolonged-Release Fampridine", 
    "pagination": "1-19", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "1e0730f2a642dd2e9b316b04a5fb2ef3ad6f51159671ce640e550b4bc56b3f07"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "30535670"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "9431220"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s40263-018-0586-5"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1110507428"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s40263-018-0586-5", 
      "https://app.dimensions.ai/details/publication/pub.1110507428"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T08:30", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000309_0000000309/records_106268_00000000.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://link.springer.com/10.1007%2Fs40263-018-0586-5"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s40263-018-0586-5'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s40263-018-0586-5'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s40263-018-0586-5'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s40263-018-0586-5'


 

This table displays all metadata directly associated to this object as RDF triples.

309 TRIPLES      21 PREDICATES      71 URIs      19 LITERALS      7 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s40263-018-0586-5 schema:about anzsrc-for:11
2 anzsrc-for:1103
3 schema:author N51799b3733f842788ff9d7506507aea2
4 schema:citation sg:pub.10.1007/s00415-015-7797-1
5 https://app.dimensions.ai/details/publication/pub.1076614093
6 https://doi.org/10.1002/9781119013563
7 https://doi.org/10.1002/acr.20346
8 https://doi.org/10.1002/ana.22240
9 https://doi.org/10.1016/j.apmr.2011.01.020
10 https://doi.org/10.1016/j.jns.2016.08.052
11 https://doi.org/10.1016/j.jpain.2007.09.005
12 https://doi.org/10.1016/j.pharmthera.2005.10.006
13 https://doi.org/10.1016/s0003-9993(98)90167-8
14 https://doi.org/10.1016/s0140-6736(09)60442-6
15 https://doi.org/10.1080/00325481.2015.1000229
16 https://doi.org/10.1080/09638280500404289
17 https://doi.org/10.1080/09638280701191859
18 https://doi.org/10.1093/brain/124.5.962
19 https://doi.org/10.1093/brain/awn116
20 https://doi.org/10.1097/01.npt.0000282258.74325.cf
21 https://doi.org/10.1097/mrr.0b013e328343d4d3
22 https://doi.org/10.1097/mrr.0b013e328350b65f
23 https://doi.org/10.1097/npt.0b013e3182097190
24 https://doi.org/10.1111/j.1532-5415.1991.tb01616.x
25 https://doi.org/10.1136/jnnp.2006.105759
26 https://doi.org/10.1161/01.str.32.7.1627
27 https://doi.org/10.1177/1352458508088916
28 https://doi.org/10.1177/1352458512444498
29 https://doi.org/10.1177/1352458512462919
30 https://doi.org/10.1177/1352458514530489
31 https://doi.org/10.1177/1352458514549396
32 https://doi.org/10.1177/1352458514563591
33 https://doi.org/10.1177/1352458514567553
34 https://doi.org/10.1177/1352458515581436
35 https://doi.org/10.1177/1352458515606809
36 https://doi.org/10.1177/1352458515622695
37 https://doi.org/10.1177/1352458517720043
38 https://doi.org/10.1177/2055217315596993
39 https://doi.org/10.1185/03007990903433528
40 https://doi.org/10.1185/03007995.2011.583229
41 https://doi.org/10.1212/wnl.0000000000003656
42 https://doi.org/10.1212/wnl.60.1.31
43 https://doi.org/10.1371/journal.pone.0165663
44 https://doi.org/10.17925/enr.2011.06.02.115
45 https://doi.org/10.2522/ptj.20060343
46 https://doi.org/10.2522/ptj.20070251
47 https://doi.org/10.3310/hta13120
48 schema:datePublished 2019-01
49 schema:datePublishedReg 2019-01-01
50 schema:description BACKGROUND: Walking impairment is a hallmark of multiple sclerosis (MS). It affects > 90% of individuals over time, reducing independence and negatively impacting health-related quality of life, productivity, and daily activities. Walking impairment is consistently reported as one of the most distressing impairments by individuals with MS. Prolonged-release (PR)-fampridine previously has been shown to improve objectively measured walking speed in walking-impaired adults with MS. The impact of PR-fampridine from the perspective of the individual with MS warrants full and detailed examination. OBJECTIVE: The objective of this study was to evaluate whether PR-fampridine has a clinically meaningful effect on self-reported walking ability in walking-impaired participants with MS. METHODS: ENHANCE was a phase III, randomized, double-blind, placebo-controlled study of PR-fampridine 10 mg twice daily in walking-impaired individuals age 18-70 years with either relapsing or progressive forms of MS and an Expanded Disability Status Scale (EDSS) score of 4.0-7.0 at screening. Participants were stratified by EDSS score (≤ 6.0 or 6.5-7.0) at randomization to ensure a balanced level of disability in the treatment groups. The primary endpoint was the proportion of participants with a mean improvement in the 12-item Multiple Sclerosis Walking Scale (MSWS-12) score exceeding the predefined threshold for clinically meaningful improvement (≥ 8 points) over 24 weeks. Secondary endpoints included the proportion with ≥ 15% improvement in Timed Up and Go (TUG) speed, and mean changes in Multiple Sclerosis Impact Scale physical impact subscale (MSIS-29 PHYS), Berg Balance Scale (BBS), and ABILHAND scores over 24 weeks. RESULTS: In total, 636 participants with MS were randomized (PR-fampridine, n = 317; placebo, n = 319; modified intention-to-treat sample: PR-fampridine, n = 315; placebo, n = 318). At baseline in the PR-fampridine and placebo groups, 46% and 51% had a progressive form of MS, median [range] EDSS scores were 6.0 [4.0-7.0] and 5.5 [4.0-7.0], mean [range] MSWS-12 scores were 63.6 [0-100] and 65.4 [0-100], and mean [range] TUG speed was 0.38 [0.0-1.0] and 0.38 [0.0-1.2] feet/s, respectively. A significantly higher percentage of PR-fampridine-treated participants (136/315 [43.2%]) had clinically meaningful improvement in MSWS-12 score over 24 weeks versus placebo (107/318 [33.6%]; odds ratio 1.61 [95% confidence interval 1.15-2.26]; p = 0.006). For PR-fampridine versus placebo, significantly more participants had a ≥ 15% improvement in TUG speed, and there was significantly greater mean improvement in MSIS-29 PHYS score (p < 0.05); numerical improvements that were not statistically significant were observed in BBS/ABILHAND. Adverse events that were more common in the PR-fampridine group than placebo group (difference ≥ 3%) by Medical Dictionary for Regulatory Activities (MedDRA®) Preferred Term were urinary tract infection and insomnia. There were no seizures reported. CONCLUSIONS: PR-fampridine treatment resulted in sustained, clinically meaningful improvements over 24 weeks in self-reported walking and functional ability in walking-disabled participants with MS. CLINICALTRIALS. GOV IDENTIFIER: NCT02219932.
51 schema:genre research_article
52 schema:inLanguage en
53 schema:isAccessibleForFree false
54 schema:isPartOf sg:journal.1111875
55 schema:name Assessment of Clinically Meaningful Improvements in Self-Reported Walking Ability in Participants with Multiple Sclerosis: Results from the Randomized, Double-Blind, Phase III ENHANCE Trial of Prolonged-Release Fampridine
56 schema:pagination 1-19
57 schema:productId N188e5f5a41734af7bb179e515d04bcd6
58 N64db81e17e4f47b1807e11c399f8532a
59 N917c93acb45e4da8a859c2412c724abb
60 N974250e3e81741508db46da02fc8dd38
61 Nd39bc128ab1b486a95538d81432fd9f3
62 schema:sameAs https://app.dimensions.ai/details/publication/pub.1110507428
63 https://doi.org/10.1007/s40263-018-0586-5
64 schema:sdDatePublished 2019-04-11T08:30
65 schema:sdLicense https://scigraph.springernature.com/explorer/license/
66 schema:sdPublisher Nf896a8c04f79491fb0e2066664f5af77
67 schema:url https://link.springer.com/10.1007%2Fs40263-018-0586-5
68 sgo:license sg:explorer/license/
69 sgo:sdDataset articles
70 rdf:type schema:ScholarlyArticle
71 N188e5f5a41734af7bb179e515d04bcd6 schema:name dimensions_id
72 schema:value pub.1110507428
73 rdf:type schema:PropertyValue
74 N22215cbb7193495ea3c7c90c4744be85 rdf:first sg:person.012135403634.76
75 rdf:rest N81499a787128437c9d7be0e734a7d14b
76 N297db8a081dc4a56b6909e3f1a3b5aa7 schema:affiliation https://www.grid.ac/institutes/grid.476070.2
77 schema:familyName Englishby
78 schema:givenName Veronica
79 rdf:type schema:Person
80 N2e8059886f29437b8325ee5bbf0cee3e rdf:first sg:person.016506013472.31
81 rdf:rest N22215cbb7193495ea3c7c90c4744be85
82 N3f96db9bae9c44a89d5603f8d0ee11a7 rdf:first sg:person.01346517240.04
83 rdf:rest Nd08e2644322d449698df88bd1d2cb559
84 N51799b3733f842788ff9d7506507aea2 rdf:first sg:person.01332375141.47
85 rdf:rest N52cfc592d52f4e2e8a6cd2b9ce5d6e7a
86 N52cfc592d52f4e2e8a6cd2b9ce5d6e7a rdf:first sg:person.0767421434.26
87 rdf:rest Nf82b729fa5324b7b938e539505e86f76
88 N64db81e17e4f47b1807e11c399f8532a schema:name readcube_id
89 schema:value 1e0730f2a642dd2e9b316b04a5fb2ef3ad6f51159671ce640e550b4bc56b3f07
90 rdf:type schema:PropertyValue
91 N668e7514b3ae4a6bb8009d6728c5f1f2 rdf:first Nf19a708c37854534a6af87090cb02672
92 rdf:rest rdf:nil
93 N81499a787128437c9d7be0e734a7d14b rdf:first sg:person.0660503170.46
94 rdf:rest Nfcf01ce01ebe49058237c6d1a7afce5b
95 N83cdc4aee96a481ab69fc61528f73b31 rdf:first N297db8a081dc4a56b6909e3f1a3b5aa7
96 rdf:rest N3f96db9bae9c44a89d5603f8d0ee11a7
97 N917c93acb45e4da8a859c2412c724abb schema:name nlm_unique_id
98 schema:value 9431220
99 rdf:type schema:PropertyValue
100 N974250e3e81741508db46da02fc8dd38 schema:name pubmed_id
101 schema:value 30535670
102 rdf:type schema:PropertyValue
103 Nd08e2644322d449698df88bd1d2cb559 rdf:first sg:person.01025220556.38
104 rdf:rest Nd73f5c2012f747deb050ee472627a9ff
105 Nd0fdaea61a0d4b6f885a5577c9a0e12d rdf:first sg:person.0632630700.05
106 rdf:rest N668e7514b3ae4a6bb8009d6728c5f1f2
107 Nd39bc128ab1b486a95538d81432fd9f3 schema:name doi
108 schema:value 10.1007/s40263-018-0586-5
109 rdf:type schema:PropertyValue
110 Nd73f5c2012f747deb050ee472627a9ff rdf:first sg:person.014347450275.96
111 rdf:rest Nd0fdaea61a0d4b6f885a5577c9a0e12d
112 Nf19a708c37854534a6af87090cb02672 schema:familyName On behalf of the ENHANCE study investigators
113 rdf:type schema:Person
114 Nf82b729fa5324b7b938e539505e86f76 rdf:first sg:person.0715702051.84
115 rdf:rest Nfd1111a623534d819f6eaa74dfc08519
116 Nf896a8c04f79491fb0e2066664f5af77 schema:name Springer Nature - SN SciGraph project
117 rdf:type schema:Organization
118 Nfcf01ce01ebe49058237c6d1a7afce5b rdf:first sg:person.01210332036.09
119 rdf:rest N83cdc4aee96a481ab69fc61528f73b31
120 Nfd1111a623534d819f6eaa74dfc08519 rdf:first sg:person.01051055517.12
121 rdf:rest N2e8059886f29437b8325ee5bbf0cee3e
122 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
123 schema:name Medical and Health Sciences
124 rdf:type schema:DefinedTerm
125 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
126 schema:name Clinical Sciences
127 rdf:type schema:DefinedTerm
128 sg:journal.1111875 schema:issn 1172-7047
129 1179-1934
130 schema:name CNS Drugs
131 rdf:type schema:Periodical
132 sg:person.01025220556.38 schema:affiliation https://www.grid.ac/institutes/grid.417832.b
133 schema:familyName Chang
134 schema:givenName Ih
135 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01025220556.38
136 rdf:type schema:Person
137 sg:person.01051055517.12 schema:affiliation https://www.grid.ac/institutes/grid.488890.5
138 schema:familyName Linnebank
139 schema:givenName Michael
140 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01051055517.12
141 rdf:type schema:Person
142 sg:person.01210332036.09 schema:affiliation https://www.grid.ac/institutes/grid.417402.4
143 schema:familyName Blight
144 schema:givenName Andrew R.
145 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01210332036.09
146 rdf:type schema:Person
147 sg:person.012135403634.76 schema:affiliation https://www.grid.ac/institutes/grid.436283.8
148 schema:familyName Farrell
149 schema:givenName Rachel
150 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012135403634.76
151 rdf:type schema:Person
152 sg:person.01332375141.47 schema:affiliation https://www.grid.ac/institutes/grid.418670.c
153 schema:familyName Hobart
154 schema:givenName Jeremy
155 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01332375141.47
156 rdf:type schema:Person
157 sg:person.01346517240.04 schema:affiliation https://www.grid.ac/institutes/grid.476070.2
158 schema:familyName McNeill
159 schema:givenName Manjit
160 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01346517240.04
161 rdf:type schema:Person
162 sg:person.014347450275.96 schema:affiliation https://www.grid.ac/institutes/grid.417832.b
163 schema:familyName Lima
164 schema:givenName Gabriel
165 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014347450275.96
166 rdf:type schema:Person
167 sg:person.016506013472.31 schema:affiliation https://www.grid.ac/institutes/grid.16416.34
168 schema:familyName Goodman
169 schema:givenName Andrew D.
170 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016506013472.31
171 rdf:type schema:Person
172 sg:person.0632630700.05 schema:affiliation https://www.grid.ac/institutes/grid.417832.b
173 schema:familyName Elkins
174 schema:givenName Jacob
175 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0632630700.05
176 rdf:type schema:Person
177 sg:person.0660503170.46 schema:affiliation https://www.grid.ac/institutes/grid.416905.f
178 schema:familyName Hupperts
179 schema:givenName Raymond
180 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0660503170.46
181 rdf:type schema:Person
182 sg:person.0715702051.84 schema:affiliation https://www.grid.ac/institutes/grid.12155.32
183 schema:familyName Feys
184 schema:givenName Peter
185 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0715702051.84
186 rdf:type schema:Person
187 sg:person.0767421434.26 schema:affiliation https://www.grid.ac/institutes/grid.4488.0
188 schema:familyName Ziemssen
189 schema:givenName Tjalf
190 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0767421434.26
191 rdf:type schema:Person
192 sg:pub.10.1007/s00415-015-7797-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033299561
193 https://doi.org/10.1007/s00415-015-7797-1
194 rdf:type schema:CreativeWork
195 https://app.dimensions.ai/details/publication/pub.1076614093 schema:CreativeWork
196 https://doi.org/10.1002/9781119013563 schema:sameAs https://app.dimensions.ai/details/publication/pub.1107030376
197 rdf:type schema:CreativeWork
198 https://doi.org/10.1002/acr.20346 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044241241
199 rdf:type schema:CreativeWork
200 https://doi.org/10.1002/ana.22240 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037626702
201 rdf:type schema:CreativeWork
202 https://doi.org/10.1016/j.apmr.2011.01.020 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020096943
203 rdf:type schema:CreativeWork
204 https://doi.org/10.1016/j.jns.2016.08.052 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050639148
205 rdf:type schema:CreativeWork
206 https://doi.org/10.1016/j.jpain.2007.09.005 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015330748
207 rdf:type schema:CreativeWork
208 https://doi.org/10.1016/j.pharmthera.2005.10.006 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041868483
209 rdf:type schema:CreativeWork
210 https://doi.org/10.1016/s0003-9993(98)90167-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006801651
211 rdf:type schema:CreativeWork
212 https://doi.org/10.1016/s0140-6736(09)60442-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000475441
213 rdf:type schema:CreativeWork
214 https://doi.org/10.1080/00325481.2015.1000229 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006623226
215 rdf:type schema:CreativeWork
216 https://doi.org/10.1080/09638280500404289 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021040532
217 rdf:type schema:CreativeWork
218 https://doi.org/10.1080/09638280701191859 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001944038
219 rdf:type schema:CreativeWork
220 https://doi.org/10.1093/brain/124.5.962 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047873684
221 rdf:type schema:CreativeWork
222 https://doi.org/10.1093/brain/awn116 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028719948
223 rdf:type schema:CreativeWork
224 https://doi.org/10.1097/01.npt.0000282258.74325.cf schema:sameAs https://app.dimensions.ai/details/publication/pub.1018450523
225 rdf:type schema:CreativeWork
226 https://doi.org/10.1097/mrr.0b013e328343d4d3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018030857
227 rdf:type schema:CreativeWork
228 https://doi.org/10.1097/mrr.0b013e328350b65f schema:sameAs https://app.dimensions.ai/details/publication/pub.1013266492
229 rdf:type schema:CreativeWork
230 https://doi.org/10.1097/npt.0b013e3182097190 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034657518
231 rdf:type schema:CreativeWork
232 https://doi.org/10.1111/j.1532-5415.1991.tb01616.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1007882864
233 rdf:type schema:CreativeWork
234 https://doi.org/10.1136/jnnp.2006.105759 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034020704
235 rdf:type schema:CreativeWork
236 https://doi.org/10.1161/01.str.32.7.1627 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013644901
237 rdf:type schema:CreativeWork
238 https://doi.org/10.1177/1352458508088916 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001802066
239 rdf:type schema:CreativeWork
240 https://doi.org/10.1177/1352458512444498 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004638456
241 rdf:type schema:CreativeWork
242 https://doi.org/10.1177/1352458512462919 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009878862
243 rdf:type schema:CreativeWork
244 https://doi.org/10.1177/1352458514530489 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008373115
245 rdf:type schema:CreativeWork
246 https://doi.org/10.1177/1352458514549396 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050747011
247 rdf:type schema:CreativeWork
248 https://doi.org/10.1177/1352458514563591 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004177395
249 rdf:type schema:CreativeWork
250 https://doi.org/10.1177/1352458514567553 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000622362
251 rdf:type schema:CreativeWork
252 https://doi.org/10.1177/1352458515581436 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003469455
253 rdf:type schema:CreativeWork
254 https://doi.org/10.1177/1352458515606809 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005629673
255 rdf:type schema:CreativeWork
256 https://doi.org/10.1177/1352458515622695 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045221739
257 rdf:type schema:CreativeWork
258 https://doi.org/10.1177/1352458517720043 schema:sameAs https://app.dimensions.ai/details/publication/pub.1090894782
259 rdf:type schema:CreativeWork
260 https://doi.org/10.1177/2055217315596993 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000226856
261 rdf:type schema:CreativeWork
262 https://doi.org/10.1185/03007990903433528 schema:sameAs https://app.dimensions.ai/details/publication/pub.1029987899
263 rdf:type schema:CreativeWork
264 https://doi.org/10.1185/03007995.2011.583229 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009204721
265 rdf:type schema:CreativeWork
266 https://doi.org/10.1212/wnl.0000000000003656 schema:sameAs https://app.dimensions.ai/details/publication/pub.1083403530
267 rdf:type schema:CreativeWork
268 https://doi.org/10.1212/wnl.60.1.31 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064381436
269 rdf:type schema:CreativeWork
270 https://doi.org/10.1371/journal.pone.0165663 schema:sameAs https://app.dimensions.ai/details/publication/pub.1023865963
271 rdf:type schema:CreativeWork
272 https://doi.org/10.17925/enr.2011.06.02.115 schema:sameAs https://app.dimensions.ai/details/publication/pub.1068543535
273 rdf:type schema:CreativeWork
274 https://doi.org/10.2522/ptj.20060343 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047265501
275 rdf:type schema:CreativeWork
276 https://doi.org/10.2522/ptj.20070251 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050952303
277 rdf:type schema:CreativeWork
278 https://doi.org/10.3310/hta13120 schema:sameAs https://app.dimensions.ai/details/publication/pub.1071139051
279 rdf:type schema:CreativeWork
280 https://www.grid.ac/institutes/grid.12155.32 schema:alternateName University of Hasselt
281 schema:name BIOMED-REVAL, University of Hasselt, Diepenbeek, Belgium
282 rdf:type schema:Organization
283 https://www.grid.ac/institutes/grid.16416.34 schema:alternateName University of Rochester
284 schema:name School of Medicine and Dentistry, University of Rochester, Rochester, NY, USA
285 rdf:type schema:Organization
286 https://www.grid.ac/institutes/grid.416905.f schema:alternateName Zuyderland Medisch Centrum
287 schema:name Zuyderland Medical Center, Sittard, The Netherlands
288 rdf:type schema:Organization
289 https://www.grid.ac/institutes/grid.417402.4 schema:alternateName Acorda Therapeutics (United States)
290 schema:name Acorda Therapeutics, Inc, Ardsley, NY, USA
291 rdf:type schema:Organization
292 https://www.grid.ac/institutes/grid.417832.b schema:alternateName Biogen (United States)
293 schema:name Biogen, Cambridge, MA, USA
294 rdf:type schema:Organization
295 https://www.grid.ac/institutes/grid.418670.c schema:alternateName University Hospitals Plymouth NHS Trust
296 schema:name Plymouth University Peninsula Schools of Medicine and Dentistry, University Hospitals Plymouth NHS Trust, N13 ITTC Building, Plymouth Science Park, PL6 8BX, Plymouth, Devon, UK
297 rdf:type schema:Organization
298 https://www.grid.ac/institutes/grid.436283.8 schema:alternateName National Hospital for Neurology and Neurosurgery
299 schema:name National Hospital for Neurology and Neurosurgery, University College London Hospitals and University College London Institute of Neurology, London, UK
300 rdf:type schema:Organization
301 https://www.grid.ac/institutes/grid.4488.0 schema:alternateName TU Dresden
302 schema:name Center of Clinical Neuroscience, Carl Gustav Carus University Clinic, Technical University of Dresden, Dresden, Germany
303 rdf:type schema:Organization
304 https://www.grid.ac/institutes/grid.476070.2 schema:alternateName Biogen (United Kingdom)
305 schema:name Biogen, Maidenhead, UK
306 rdf:type schema:Organization
307 https://www.grid.ac/institutes/grid.488890.5 schema:alternateName Helios Klinik Hagen Ambrock
308 schema:name HELIOS Klinik Hagen-Ambrock, University Witten/Herdecke, Hagen, Germany
309 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...